Long-term safety and tolerability of nintedanib in patients with idiopathic pulmonary fibrosis: results from the open-label extension study, INPULSIS-ON

2018236 citationsJournal Article

Authors

Good health and well-being

Published in: The Lancet Respiratory Medicine

Volume 7, Issue 1, pp. 60-68

Field-Weighted Citation Impact: 19.43